<VariationArchive VariationID="29638" VariationName="NM_000090.4(COL3A1):c.479dup (p.Lys161fs)" VariationType="Duplication" Accession="VCV000029638" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-15" DateCreated="2019-03-10" MostRecentSubmission="2019-03-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="38592" VariationID="29638">
      <GeneList>
        <Gene Symbol="COL3A1" FullName="collagen type III alpha 1 chain" GeneID="1281" HGNC_ID="HGNC:2201" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q32.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="188974373" stop="189012746" display_start="188974373" display_stop="189012746" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NW_025791764.1" start="79333" stop="117706" display_start="79333" display_stop="117706" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="189839098" stop="189877471" display_start="189839098" display_stop="189877471" Strand="+" />
          </Location>
          <OMIM>120180</OMIM>
          <Haploinsufficiency last_evaluated="2017-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL3A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL3A1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000090.4(COL3A1):c.479dup (p.Lys161fs)</Name>
      <CanonicalSPDI>NC_000002.12:188987089:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q32.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="188987089" stop="188987090" display_start="188987089" display_stop="188987090" variantLength="1" positionVCF="188987089" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="189851815" stop="189851816" display_start="189851815" display_stop="189851816" variantLength="1" positionVCF="189851815" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
      </Location>
      <ProteinChange>K161fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.189851816dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.189851816dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.188987090dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.188987090dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007404.1" sequenceAccession="NG_007404" sequenceVersion="1" change="g.17718dup">
            <Expression>NG_007404.1:g.17718dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000090.4" sequenceAccession="NM_000090" sequenceVersion="4" change="c.479dup" MANESelect="true">
            <Expression>NM_000090.4:c.479dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000081.2" sequenceAccession="NP_000081" sequenceVersion="2" change="p.Lys161fs">
            <Expression>NP_000081.2:p.Lys161fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_3" sequenceAccession="LRG_3">
            <Expression>LRG_3:g.17718dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_3t1" sequenceAccession="LRG_3t1">
            <Expression>LRG_3t1:c.479dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_3p1" sequenceAccession="LRG_3p1" change="p.Lys161fs">
            <Expression>LRG_3p1:p.Lys161fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA006886" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="120180.0034" DB="OMIM" />
        <XRef Type="rs" ID="397509377" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000090.4(COL3A1):c.479dup (p.Lys161fs) AND Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome" Accession="RCV000022485" Version="31">
        <ClassifiedConditionList TraitSetID="46476">
          <ClassifiedCondition DB="MedGen" ID="C5193040">Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2009-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2009-11-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-03-10" MostRecentSubmission="2019-03-10">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11577371</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19455184</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9050868</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="46476" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="41437" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome</ElementValue>
                <XRef ID="MONDO:0032688" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PMGEDSV</ElementValue>
                <XRef Type="MIM" ID="618343" DB="OMIM" />
              </Symbol>
              <XRef ID="636941" DB="Orphanet" />
              <XRef ID="C5193040" DB="MedGen" />
              <XRef ID="MONDO:0032688" DB="MONDO" />
              <XRef Type="MIM" ID="618343" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="49030" SubmissionDate="2019-03-05" DateLastUpdated="2019-03-10" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="120180.0034_POLYMICROGYRIA WITH VASCULAR-TYPE EHLERS-DANLOS SYNDROME" title="COL3A1, 1-BP DUP, 479T_POLYMICROGYRIA WITH VASCULAR-TYPE EHLERS-DANLOS SYNDROME" />
        <ClinVarAccession Accession="SCV000043774" DateUpdated="2019-03-10" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2009-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 11-year-old French girl, born of consanguineous parents, with polymicrogyria with vascular-type EDS (PMGEDSV; 618343), Plancke et al. (2009) identified a homozygous 1-bp duplication (c.479dupT) in exon 5 of the COL3A1 gene, resulting in a frameshift and premature termination (Lys161GlnfsTer45). The transmission pattern was consistent with autosomal recessive inheritance. She had thin, translucent skin with marked scars, early-onset varicose veins, hypermobility of the small joints, gingival recession, hypoplastic nasal alae, and think lips. She also had delayed motor development, absence epilepsy, and diffuse cortical dysplasia. She presented with acute abdominal pain, and surgery revealed extreme intestinal, arterial, and tissue fragility. She died after surgery from multiple perforations, suture breakdown, and total evisceration. The patient's unaffected parents were each heterozygous for the mutation. The mutation was shown to result in nonsense-mediated decay. The lack of phenotype in the parents was discussed by Plancke et al. (2009) in light of the study by Schwarze et al. (2001), who reported a severe phenotype resulting from COL3A1 haploinsufficiency due to truncating mutations. Plancke et al. (2009) noted that heterozygous Col3a1-null mice have no phenotype (Liu et al., 1997), similar to the parents of their French patient. Plancke et al. (2009) also noted that the nonsense-mediated mRNA process is inefficient and, in the cases of Schwarze et al. (2001), could have resulted in the production of a small amount of protein with dominant-negative effects.</Attribute>
              <Citation>
                <ID Source="PubMed">19455184</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11577371</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9050868</ID>
              </Citation>
              <XRef DB="OMIM" ID="618343" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL3A1" />
          </GeneList>
          <Name>COL3A1, 1-BP DUP, 479T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 479T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="120180.0034" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">POLYMICROGYRIA WITH VASCULAR-TYPE EHLERS-DANLOS SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
  </ClassifiedRecord>
</VariationArchive>

